Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in TaxesChange in TaxesGains from Equity InvestmentsGains from Equity InvestmentsGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Gains from Investment Securities (2016 - 2025)

Zepp Health has reported Gains from Investment Securities over the past 9 years, most recently at $1.5 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.5 million, changed N/A, while the annual FY2025 figure was $1.5 million, 2526.03% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $1.5 million at Zepp Health, up from $120774.3 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.5 million in Q4 2025 and troughed at $14197.1 in Q4 2022.
  • A 4-year average of $752839.2 and a median of $763291.8 in 2021 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: crashed 98.99% in 2022 and later soared 750.7% in 2023.
  • Year by year, Gains from Investment Securities stood at $1.4 million in 2021, then crashed by 98.99% to $14197.1 in 2022, then soared by 750.7% to $120774.3 in 2023, then surged by 1117.62% to $1.5 million in 2025.
  • Business Quant data shows Gains from Investment Securities for ZEPP at $1.5 million in Q4 2025, $120774.3 in Q4 2023, and $14197.1 in Q4 2022.